Podcasts about aids relief pepfar

About this episode: In 2003, George W. Bush's President's Emergency Plan for AIDS Relief (PEPFAR) was the largest commitment to a single disease in U.S. history. Renewed under every subsequent presidency since, PEPFAR has saved more than 25 million lives and prevented some 5 million perinatal infections globally. But now, policy changes that effectively end PEPFAR have the potential to completely reverse course and the world could see HIV/AIDS infections on par with a time even before effective antivirals existed. In this episode: Dr. Chris Beyrer talks about his recent Lancet essay, “On Going Backwards,” why any retreat now will make it harder to regain lost ground, and how this policy change has the potential to impact millions of lives. Guest: Dr. Chris Beyrer is the past president of the International AIDS Society and an expert in global health and human rights. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs at the Johns Hopkins Bloomberg School of Public Health. Show links and related content: On Going Backwards—The Lancet (Perspectives) By executive order: The likely deadly consequences associated with a 90-day pause in PEPFAR funding—Journal of the International AIDS Society Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Lester Kiewit speaks to Lwazi Mazibuko, Programs Manager at Parents, Families & Friends of South African Queers, about how the trans community is dealing with the withdrawal of the U.S President’s Emergency Plan for AIDS Relief (PEPFAR) and National Institutes of Health (NIH) research grants. Good Morning Cape Town with Lester Kiewit is a podcast of the CapeTalk breakfast show. This programme is your authentic Cape Town wake-up call. Good Morning Cape Town with Lester Kiewit is informative, enlightening and accessible. The team’s ability to spot & share relevant and unusual stories make the programme inclusive and thought-provoking. Don’t miss the popular World View feature at 7:45am daily. Listen out for #LesterInYourLounge which is an outside broadcast – from the home of a listener in a different part of Cape Town - on the first Wednesday of every month. This show introduces you to interesting Capetonians as well as their favourite communities, habits, local personalities and neighbourhood news. Thank you for listening to a podcast from Good Morning Cape Town with Lester Kiewit. Listen live – Good Morning CapeTalk with Lester Kiewit is broadcast weekdays between 06:00 and 09:00 (SA Time) https://www.primediaplus.com/station/capetalk Find all the catch-up podcasts here https://www.primediaplus.com/capetalk/good-morning-cape-town-with-lester-kiewit/audio-podcasts/good-morning-cape-town-with-lester-kiewit/ Subscribe to the CapeTalk daily and weekly newsletters https://www.primediaplus.com/competitions/newsletter-subscription/ Follow us on social media: CapeTalk on Facebook: www.facebook.com/CapeTalk   CapeTalk on TikTok: www.tiktok.com/@capetalk   CapeTalk on Instagram: www.instagram.com/capetalkza  CapeTalk on X: www.x.com/CapeTalk  CapeTalk on YouTube: www.youtube.com/@CapeTalk567  See omnystudio.com/listener for privacy information.

Bongani Bingwa in conversation with GroundUp Reporter Daniel Steyn about how many South African health programs are still supported by the US President's Emergency Plan for AIDS Relief (PEPFAR), and how the victims of Operation Dudula are demanding justice. See omnystudio.com/listener for privacy information.

The decision by the US government to temporarily freeze funding to the President's Emergency Plan for AIDS Relief (PEPFAR) alongside all other foreign aid for at least 90 days has had immediate effects on people living with HIV according to Doctors Without Borders (MSF). The independent medical humanitarian organisation says although the US has since clarified that certain treatment programs can continue at least until April, it is still concerned that critical elements of the PEPFAR program remain frozen. President Donald Trump's administration announced the huge cuts while it undertakes a "review" to ensure they align with President Trump's priorities or agenda. Experts in global health have been expressing their dismay and concern over the dismantling of the United States Agency for International Development (USAID), which distributes tens of billions of dollars' worth of overseas aid every year. On THURSDAY , A federal judge ordered Donald Trump's administration to temporarily lift the funding freeze and has set a five-day deadline for the administration to prove it is complying. To look at the impact and how Africa can move forward Bongiwe Zwane spoke to Professor Ntobeko Ntusi, President and CEO of the South African Medical Research Council and Tom Ellman, Head of the Southern Africa Medical Unit at Doctors Without Borders

World Health Organization Director-General Tedros Adhanom Ghebreyesus says that the United States' pause on foreign aid contributions is having a serious impact on global health, hitting programs fighting polio, HIV and other threats. Tedros urged the U.S. to consider resuming aid funding until solutions can be found. Tedros said that the suspension of funding for the President's Emergency Plan for AIDS Relief (PEPFAR) had caused an immediate stop to HIV treatment, testing and prevention services in the 50 countries it supports.

Apoorva Mandavilli, the award-winning New York Times science and global health reporter, is on the front lines of several fast-breaking stories. “We should be worried” about the President's Emergency Plan for AIDS Relief (PEPFAR). It was “already on the chopping block” before the hugely disruptive Trump pause on national grants and contracts. Secretary Rubio did issue a waiver, but there has been no follow-up clarification. PEPFAR remains in peril. Many bad things happen rapidly when a sensitive, complex program of this scale is disrupted. “The virus comes roaring back.” Though Robert F. Kennedy Jr.'s confirmation hearing to be HHS Secretary appears inconclusive, Apoorva was “not expecting the level of fireworks.” RFK Jr. was “damned by his own history” of false statements on vaccines, which “haunted him.” U.S. withdrawal from WHO is bad news for Americans in several concrete ways that will harm U.S. national interests. She has brought to our attention that scientists believe we have entered a new, far more dangerous phase in the evolution of the H5N1 threat, while the U.S. response remains woeful. 

This episode of HIV unmuted features an intimate conversation with Ambassador-at-Large Dr John N Nkengasong, the U.S. Global AIDS Coordinator and Senior Bureau Official for Global Health Security and Diplomacy (GHSD). Our host,Juan Michael Porter II, takes listeners through John N Nkengasong's remarkable journey from his early days as a virologist to his current role leading the State Department's Bureau of GHSD, which oversees the global implementation of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). John N Nkengasong offers profound insights into the ongoing global HIV response, stressing the importance of community leadership in sustaining the progress made over the years. He addresses the challenges of maintaining this momentum in the face of changing global health priorities and funding landscapes. Despite significant advancements in treatment and prevention, John N Nkengasong underscores that ending the HIV pandemic will require addressing persistent inequalities and engaging communities around the world.  John N Nkengasong also highlights the potential of lenacapavir for HIV prevention, which, as of December 2024, is part of a coordinated effort by PEPFAR, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Children's Investment Fund Foundation and the Gates Foundation to expand access to innovative treatments. Learn more about this initiative here. Meet our guest: John N Nkengasong is an Ambassador-at-Large and serves as the U.S. Department of State's U.S. Global AIDS Coordinator and Senior Bureau Official for Global Health Security and Diplomacy (GHSD). He oversees the Bureau of Global Health Security and Diplomacy, which serves as the department's coordinating body for work on strengthening global health security to prevent, detect and respond to infectious diseases, including HIV and AIDS. The department also elevates and integrates global health security as a core component of U.S. national security and foreign policy. GHSD is home to the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), which the Ambassador also oversees. PEPFAR is the largest commitment by any nation to address a single disease in history and has prevented millions of HIV acquisitions, saved more than 25 million lives, and changed the course of the HIV pandemic.Meet our host: Juan Michael Porter II is a health journalist, HIV advocate, culture critic, educator and the host of HIV unmuted, the IAS podcast. He is the Senior Editor of TheBody.com and TheBodyPro – and the first person openly living with HIV to hold the position. Juan Michael's reporting combines data dives, personal narratives and policy analyses to address the real-world consequences of ever-shifting legislation on people's health outcomes. He has written for the Public Broadcasting Service, SF Chronicle, Philadelphia Inquirer, Christian Science Monitor, NY Observer, TDF Stages, Playbill, American Theatre, Time Out NY, Queerty, Anti-Racism Daily, Positively Aware, Documentary Magazine, SYFY Wire, Scholastic and Dance Magazine.

This December 1st, Project HOPE was among the many organizations commemorating World AIDS Day as well as the 16 Days of Activism Against Gender-Based Violence. Over two decades, significant progress in HIV control, particularly in Africa, has been achieved through initiatives like President's Emergency Plan for AIDS Relief (PEPFAR). Since 2003, PEPFAR has enabled over 20 million people to access antiretroviral therapy and prevented 5.5 million HIV-positive births. However, challenges persist in meeting UNAIDS' 95-95-95 targets—ensuring widespread testing, treatment, and viral suppression. Barriers include funding shortages, stigma, and competing health crises like COVID-19. Adolescents, especially girls and young women, face heightened risk due to social vulnerabilities and limited access to youth-friendly services. Mvemba is joined by Dr. Uche Ralph-Opara, Chief Health Officer at Project HOPE, to discuss the progress made and the hurdles that remain in achieving epidemic control. Their conversation highlights innovative approaches to addressing gender inequality and empowering vulnerable populations.

On the podcast today we have Juan Flores, Public Health Advisor from the U.S. State Department's U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program. We'll talk about the latest efforts on the global fight against HIV. And hey, we got some great news for you: HIV transmission rates are further down compared to prior years.

Dr. Rochelle Walensky served as the 19th Director of the Centers for Disease Control and Prevention (2021-23), Professor of Medicine, Harvard Medical School (2012-2021), and Chief of the Division of Infectious Diseases, Massachusetts General Hospital (2017-2021). Dr. Walensky is an infectious disease clinician whose research career is guided by a belief that the clinical and economic outcomes of medical decisions can be improved through the explicit articulation of choices, the systematic assembly of evidence, and the careful assessment of comparative costs and benefits. She has focused these beliefs on mathematical model-based research toward the promotion of global access to HIV prevention, screening, and care. Her ground-breaking work and over 300 research publications have motivated changes to US HIV testing and immigration policy; promoted expanded funding for HIV-related research, treatment, and the President's Emergency Plan for AIDS Relief (PEPfAR); and led to policy revisions toward aggressive HIV screening – especially for the underserved – and earlier treatment in resource-limited international settings. In light of these contributions, Dr. Walensky has been an active member of policy discussions at the WHO, UNAIDS, the DHHS HIV Guidelines Committee, and the NIH Office of AIDS Research.

SA pharmaceutical manufacturers have called on the US President's Emergency Plan for Aids Relief (Pepfar) to procure more HIV/Aids medicines from African producers, arguing this will boost the continent's drug making capacity and provide protection against future health security threats. Pepfar is the world's biggest HIV/Aids donor and is credited with saving more than 25-million lives with the more than $110bn it has provided over the past two decades to the countries hardest hit by the disease, including SA. NOLUTHANDO MTHONTI-MLAMBO speaks to Stavros Nicolaou, Chairperson, Pharmaceuticals Made in SA (Pharmisa).See omnystudio.com/listener for privacy information.

Dr. Anthony S. Fauci is Distinguished University Professor in the Georgetown University School of Medicine's Department of Medicine, in the Division of Infectious Diseases ( https://medicine.georgetown.edu/divisions/infectiousdiseases/ ), an academic division that provides clinical care, conducts research and trains future physicians in infectious diseases. He also holds an additional appointment in the university's McCourt School of Public Policy. Dr. Fauci served as U.S. National Institute of Allergy and Infectious Diseases (NIAID) Director from 1984 to 2022. He oversaw an extensive research portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis, and malaria as well as emerging diseases such as Ebola, Zika and COVID-19. He also led the NIAID research effort on transplantation and immune-related illnesses, including autoimmune disorders, asthma, and allergies ( https://www.niaid.nih.gov/about/anthony-s-fauci-md-bio ) . Dr. Fauci advised seven Presidents on HIV/AIDS and many other domestic and global health issues. He was one of the principal architects of the President's Emergency Plan for AIDS Relief (PEPFAR), a program that has saved more than 20 million lives throughout the developing world. Dr. Fauci was a key advisor to seven Presidents and their administrations on global HIV/AIDS issues, and on initiatives to bolster medical and public health preparedness against emerging infectious disease threats such as pandemic influenza and COVID-19. As an HIV/AIDS researcher he was involved in the scientific effort since AIDS was recognized in 1981, conducting pivotal studies that underpin the current understanding of the disease and efforts to develop therapies and tools of prevention. Dr. Fauci was the longtime chief of the Laboratory of Immunoregulation. He made many contributions to basic and clinical research on the pathogenesis and treatment of immune-mediated and infectious diseases. He helped pioneer the field of human immunoregulation by making important basic scientific observations that underpin the current understanding of the regulation of the human immune response. In addition, Dr. Fauci is widely recognized for delineating the precise ways that immunosuppressive agents modulate the human immune response. He developed effective therapies for formerly fatal inflammatory and immune-mediated diseases such as polyarteritis nodosa, granulomatosis with polyangiitis (formerly Wegener's granulomatosis), and lymphomatoid granulomatosis. Dr. Fauci made seminal contributions to the understanding of how HIV destroys the body's defenses leading to its susceptibility to deadly infections. Further, he was instrumental in developing treatments that enable people with HIV to live long and active lives. In a 2022 analysis of Google Scholar citations, Dr. Fauci ranked as the 44th most-cited living researcher. According to the Web of Science, Dr. Fauci ranked 9th out of 3.3 million authors in the field of immunology by total citation count between 1980 and April 2022. During the same period, he ranked 22th out of 3.3 million authors in the field of research & experimental medicine, and 715th out of 1.4 million authors in the field of general & internal medicine. Dr. Fauci has delivered major lectures all over the world and is the recipient of numerous prestigious awards, including the Presidential Medal of Freedom (the highest honor given to a civilian by the President of the United States), the National Medal of Science, the George M. Kober Medal of the Association of American Physicians, the Mary Woodard Lasker Award for Public Service, the Albany Medical Center Prize in Medicine and Biomedical Research, the Robert Koch Gold Medal, the Prince Mahidol Award, and the Canada Gairdner Global Health Award. Support the show

Today, panelists, Ashley Frost and James Maloney, Deputy Directors, Office of HIV/AIDS USAID, discussed USAID's localization initiative, locally-led development, and the importance of diversified local partners. They discuss USAID's Global Health work, how USAID supported PEPFAR and the successes it has enjoyed, including statistics of lives saved and changed.   James Maloney and Ashley Frost share the new PEPFAR five-year strategy, the USAID Approach to HIV and Optimized Programming (AHOP). AHOP is a framework for USAID to employ assets through efficient, measured, and simplified programmatic approaches to ensure resilient and country-led approaches to the HIV response. The AHOP defines five critical pathways through which USAID will assist countries in sustaining epidemic control and accelerating progress in those that have not yet achieved the 95-95-95 goals. Each pathway outlines planned results and time-bound milestones. If this resonates with you, share successes with Congress to fund the five-year reauthorization of PEPFAR.   IN THIS EPISODE: [00:32] Mike Shanley outlines key talking points regarding the accomplishments that PEPFAR has achieved over the last 20 years, delivering unprecedented impact in the global fight against HIV AIDS.  [02:57] Ashley Frost and James Maloney describe their roles at USAID as Deputy Directors.  [04:40] Discussion where funding originates, the investments they make at the primary healthcare level, and successes they have accomplished through PEPFAR, stating that USAID is the largest donor and they are advancing work in the HIV vaccine space.  [11:00] James shares statistics of the impact made in the world attributed to PEPFAR and reflects on the history of growth and prevention.  [14:50] Discussion of localization, local entities and partners and relationships within country-led staff and senior diplomats in their countries.         [20:06] Looking forward to goals and objectives, James discusses the AHOP framework in response to HIV.  [25:24] Ashley comments on the importance of keeping an open dialogue between all partners within the HIV AIDS space, and James outlines the importance of seeing the 5-year reauthorization of PEPFAR.    KEY TAKEAWAYS:  Oftentimes, hospitals and building new infrastructure is what gets a “ribbon cutting”, but in terms of buying the best health outcome with USAID's investments from U.S. taxpayers, the first area of importance is investments made at a primary care level, which will most impact healthcare outcomes, saving lives and supporting healthy lives. The second thing that drives a lot of USAID's investments across individual disease or health areas is health security. Much of PEPFAR's success lies in engaging with local partners. With regard to localization, the Office of HIV AIDS and the Global Health Bureau have been the front runners in the agency and have been able to guide our agency in these spaces. Right now, about 58 percent of our resources are implemented through local entities, and those sets of partners have been diversified. Small business engagement in the U.S. is essential and has much to offer to the work we can accomplish together. More significant international partners have specific skill sets that are necessary for USAID. As we think about localization, everyone needs to think outside the box and remember that one size does not fit all.  By the end of 2025, the vision is to help countries reach what the USAID calls the global commitment of 95-95-95 goals. That means that 95 percent of those who have HIV know their status. 95 percent of those individuals are on treatment, and 95 percent of those individuals would be virally suppressed. The AHOP defines five critical pathways through which USAID will assist countries in attaining these goals.  RESOURCES: Aid Market Podcast Aid Market Podcast YouTube Mike Shanley - LinkedIn James Maloney - LinkedIn USAID Approach to HIV and Optimized Programming   BIOGRAPHIES:  James Maloney has served as the Deputy Director for the Office of HIV/AIDS (OHA) within the Global Health Bureau at the United States Agency for International Development (USAID) since March 2020. OHA provides overall programmatic guidance for USAID's implementation of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and oversight of $4 billion in 53 countries. In March 2022, following Russia's invasion of Ukraine, James was asked to support the National Security Council Global Health Development Directorate and serve as the Coordinator for the Ukraine and Regional Health working group. In October 2022, James was designated as the Senior Operations Official for the Global Mpox Response Team and has led coordination of the United States' global response to mpox. Previously, James led the Supply Chain for Health Division at USAID overseeing over $700 million per year in HIV commodity procurement and supply chain management to advance HIV epidemic control and strengthen the capacity of countries to manage health supply chains. Prior to joining USAID Washington, James served as Senior Technical Advisor from 2015 to 2018 with USAID Haiti managing primary health care and supply chain programs to improve the availability, quality and utilization of health services in the areas of maternal and child health, HIV and TB, reproductive health, nutrition, and WASH. Prior to Haiti, James worked in South Africa from January 2010 with the Department of State and served as the Country Coordinator for PEPFAR and lead the U.S. Government's interagency response to HIV/AIDS in South Africa.     Ashley Frost joined the Office of HIV/AIDS (OHA) as Deputy Director in August 2023. As a Foreign Service Officer, she most recently served as Health Office Director for USAID/Southern Africa. Over the last decade, she has served as Deputy Director for Operations, Care and Treatment Lead, and Strategic Information (SI) Lead, supporting USAID's PEPFAR programming in South Africa, Zambia, and Guatemala/Central America. Ashley holds a Ph.D. in Sociology and Demography from Penn State University, and her academic work includes quantitative and qualitative research in HIV, reproductive health, and gender. Before joining USAID in 2011, she worked with Congressional staff members, international researchers, policymakers, and program managers to improve evidence-based decisions for public health outcomes. She served as an education Peace Corps Volunteer in Benin, West Africa. Fun Facts: Ashley has three sons (ages 12, 9, and 9), and they do many sports as a family! They spend their free time jogging, biking, hiking, and attending many soccer games. Ashley and her husband, Jason, are section hiking the Appalachian trail each year and have walked through Georgia, North Carolina, and Tennessee together. Degrees: MA, PhD in Sociology and Demography, Languages: English, Spanish, French (comprehension)  

Welcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio. This is: PEPFAR, one of the most life-saving global health programs, is at risk, published by salonium on December 10, 2023 on The Effective Altruism Forum. Summary: International funding and coordination to tackle HIV/AIDS and support health systems in lower- and middle-income countries, is at risk of not being renewed by US Congress, due to demands that it should be linked to new abortion-related restrictions in recipient countries. This program is estimated to have saved over 20 million lives since it was launched by the Bush Administration in 2003, and even now averts over a million HIV/AIDS deaths annually. Since it has also helped support health systems in LMICs, and tackle malaria and tuberculosis, its impact is likely greater than this. In my view this is the most important risk to global health we face today, and I think it isn't getting enough attention. If anyone is interested in research, writing or advocacy on this issue, please do so. If you are interested in jointly working on this, or if you already know of ongoing efforts, please comment below or get in touch. My email: saloni@ourworldindata.org Relevant background reading: The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), the largest commitment in history by any single country to address a disease, is estimated to have averted 25 million deaths from AIDS and enabled 5.5 million babies to be born free from HIV infection over the past 20 years.1 It has provided more than $100 billion in funding for HIV prevention, care, and treatment internationally, supporting 55 low- and middle-income countries that are collectively home to 78% of all people living with HIV. Together with the Global Fund to Fight AIDS, Tuberculosis, and Malaria, PEPFAR has transformed AIDS in low-income countries, especially those in Africa, from a death sentence to a readily treatable chronic disease by deploying programs that provide antiretroviral treatment even in the most remote villages. Right from the start, PEPFAR was more than just an AIDS program; it partnered with countries in Africa to support the development of health systems for essential community services, trained thousands of health care workers, fostered security and stability in affected countries, and engendered hope amid a devastating global AIDS crisis. Karim et al. (2023) Why is it at risk? Republican colleagues [...] accuse the Biden administration of using PEPFAR to fund abortion providers overseas and House Democrats who refuse to reinstate Trump administration rules that prohibited foreign aid going to groups that provide or counsel on abortions. Discussions about a compromise that would extend the program for more than one year but less than five, with language stressing the existing ban on federal money directly paying for abortions, have collapsed. Now, the best hope for re-upping the $7 billion annual program is a government spending process beset by delays and divisions and slated to drag into January and February with no guarantee of success. PEPFAR can hobble along without reauthorization unless there's a prolonged government shutdown. But its backers say that without a long-term U.S. commitment, groups fighting HIV and AIDS around the world will struggle to hire staff and launch long-term projects. Complicating any hope for compromise is the 2024 election. Congress passed two short-term funding patches that expire in January and February. That eliminated the possibility of the typical end-of-year omnibus bill that many on both sides of the PEPFAR fight saw as the best vehicle for its reauthorization and kicked the fight into an election year when compromise - particularly on a contentious issue like abortion - will be more challenging. Politico [7 Dec. 2023] The lawmakers stalling the reauthorization are seeking to impose on PEPFAR a prohibition...

Jasmin and Reese discuss congestion pricing for those driving into Manhattan, the President's Emergency Plan for AIDS Relief (PEPFAR) being in danger, the Russian Supreme Court bans LGBTQ+ "movement", and a court win for minimum wages for NYC delivery workers.

Friday marks the 35th World AIDS Day and 20th anniversary of the United States President's Emergency Plan for AIDS Relief (PEPFAR). The theme for World AIDS Day 35 is “Remember and Commit.” A lot has changed since the Centers for Disease Control and Prevention first defined HIV/AIDS in 1981. The U.S. Department of Health and Human Services recently set a collaborative goal to end the HIV epidemic by 2030. On Friday's special edition of “Closer Look with Rose Scott,” Rose talks with guests about the progress and continuing challenges in combating the disease in the state of Georgia. Guests include: Daphne Walker, the division director for the Housing Assistance Division at Georgia Department of Community Affairs Dr. Patrick Sullivan, an AIDSVu principal scientist and a professor of epidemiology at Emory University's Rollins School of Public Health Mia Allison, an assistant pastor at Hope For Tomorrow Deliverance Center WABE Host and reporter Jim BurressSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Assistant Secretary General / Deputy Executive Director, Programs UNAIDS, Angeli Achrekar, on the improvement in HIV transmission, US President Joe Biden's Emergency Plan for Aids Relief (Pepfar) as the largest foreign donor to South Africa's HIV/AIDS fighting efforts, and whether there is a connection between Pepfar and abortions. See omnystudio.com/listener for privacy information.

GDP Script/ Top Stories for Nov 12th  Publish Date:  Nov 10th HENSSLER 15 From the Henssler Financial Studio Welcome to the Gwinnett Daily Post Podcast. Today is Friday, November 10th and Happy 78th Birthday to announcer Al Michael. ***MIRACLE ON ICE*** I'm Bruce Jenkins and here are your top stories presented by Peggy Slappy Properties. Gwinnett County's Veteran and Family Services Center Helps Vets Navigate Process Of Getting Help Piedmont Eastside Recognizes Gwinnett Fire Supervisor As A Hero Georgia Transportation Commissioner Russell McMurry Says State's Work With Gwinnett County On Smart Corridors Is The Future Of Travel All of this and more is coming up on the Gwinnett Daily Post podcast, and if you are looking for community news, we encourage you to listen daily and subscribe! Break 1: Peggy Slappy   STORY 1: Gwinnett County's Veteran and Family Services Center Helps Vets Navigate Process Of Getting Help The Gwinnett County Veterans and Family Services Center in Lawrenceville, Georgia, is providing essential assistance to veterans, offering guidance on navigating the Veterans Administration and accessing mental health services. The center, established in collaboration with Disabled American Veterans Chapter 90, aims to address the needs of veterans and their families. The facility has expanded space compared to its previous location, and Gwinnett County Commissioner Jasper Watkins emphasized the importance of creating a comfortable environment for veterans to decompress. The center recently hosted a Stand Down event, providing veterans and their families with information, health screenings, and support services.   STORY 2: Piedmont Eastside Recognizes Gwinnett Fire Supervisor As A Hero Gwinnett County Fire and Emergency Service Lt. Sam Ballouk has been recognized as a "Hero" by Piedmont Eastside Medical Center for his commitment to community safety. Ballouk, who serves as the A-Shift medical supervisor, has extensive experience in the fire department and worked as a paramedic for Walton County EMS. The recognition is part of Piedmont Eastside's First Friday Hero program, which acknowledges first responders exceeding their duty. Ballouk expressed his dedication to the EMS field, emphasizing the importance of treating every patient with respect and fostering collaboration between fire, EMS, and hospitals.   STORY 3: Georgia Transportation Commissioner Russell McMurry Says State's Work With Gwinnett County On Smart Corridors Is The Future Of Travel Georgia Department of Transportation Commissioner Russell McMurry discussed future transportation plans during a presentation to the Gwinnett Chamber. Emphasizing the importance of technology, McMurry highlighted smart corridors in Gwinnett County, where fiber optic connectivity to traffic signals aims to communicate information to vehicles. The projects on Buford Highway, Arcado Road, and State Route 120 involve underground infrastructure, making the changes noninvasive for drivers. McMurry anticipates increased technology integration, allowing cars to receive traffic signal information and potentially act independently based on safety parameters. The initiatives align with Georgia's commitment to advancing transportation technology.   We have opportunities for sponsors to get great engagement on these shows. Call 770.874.3200 for more info. We'll be right back Break 2: MOG – TOM WAGES – ESOG   STORY 4: Editorial: Toxic politics envelop noble AIDS program The President's Emergency Plan for AIDS Relief (PEPFAR), initiated by President George W. Bush in 2003, faces challenges as some lawmakers allege the Biden administration of promoting abortion in the program. PEPFAR has played a crucial role in combating AIDS globally, saving an estimated 25 million lives and preventing infections in infants. Despite enjoying bipartisan support in the past, recent claims have delayed reauthorization and hindered fund disbursement. Critics argue that the allegations lack substance, and PEPFAR's focus remains on HIV prevention and treatment. The delay in funding could impact the program's effectiveness and raise questions about the nation's commitment to global health initiatives.   STORY 5: Special toothpaste could save lives of people with peanut allergies A specialized toothpaste containing tiny amounts of peanut could offer a breakthrough in treating peanut allergies. The toothpaste, part of Oral Mucosal Immunotherapy (OMIT), aims to build patients' immunity by exposing them to small amounts of the allergen over time. In a trial, all participants tolerated the highest dose of peanut toothpaste without severe reactions. OMIT could be a safe and convenient option for adults with food allergies, supporting continued development, according to allergy expert Dr. William Berger. The results encourage further exploration of the toothpaste's potential, particularly in pediatric populations.   We'll be back in a moment   Break 3: DTL – INGLES 7 - JACKSON EMC   STORY 6: Kentucky's Constitution still allows for slavery. A group of teens is pushing to change it The existence of an exception clause in Section 25 of the Kentucky Constitution that allows slavery and involuntary servitude as punishment for crime. The clause, similar to the 13th Amendment of the U.S. Constitution, has raised concerns, prompting efforts to remove it through a constitutional amendment. Members of the South Elkhorn Christian Church youth group testified before the legislature's Joint Commission on Race and Access to Opportunity Committee, urging the removal of the exception clause. Advocates argue that the clause has historical ties to discriminatory practices and systemic racism, emphasizing the need for constitutional change.     STORY 7: Beer industry enters fray in battle over rum tax benefits The beer lobby is challenging the renewal of a tax benefit for Puerto Rico and the U.S. Virgin Islands, known as the "rum cover-over," claiming it unfairly subsidizes rum-producing competitors. The tax dispute arises amid broader tensions between the beer and spirits industries over the taxation of new alcoholic beverage options. The beer lobby argues that the rum cover-over program benefits large liquor companies and calls for a reevaluation of the program to ensure the territories receive appropriate assistance. The disagreement adds complexity to the potential renewal of the rum cover-over as part of a year-end tax package.   We'll have final thoughts after this.   Break 4: Henssler 60   Signoff – Thanks again for hanging out with us on today's Gwinnett Daily Post podcast. If you enjoy these shows, we encourage you to check out our other offerings, like the Cherokee Tribune Ledger Podcast, the Marietta Daily Journal, the Community Podcast for Rockdale Newton and Morgan Counties, or the Paulding County News Podcast. Read more about all our stories, and get other great content at Gwinnettdailypost.com. Did you know over 50% of Americans listen to podcasts weekly? Giving you important news about our community and telling great stories are what we do. Make sure you join us for our next episode and be sure to share this podcast on social media with your friends and family. Add us to your Alexa Flash Briefing or your Google Home Briefing and be sure to like, follow, and subscribe wherever you get your podcasts. www.wagesfuneralhome.com  www.psponline.com www.mallofgeorgiachryslerdodgejeep.com  www.esogrepair.com www.henssler.com  www.ingles-markets.com  www.downtownlawrencevillega.com  www.gcpsk12.org  www.cummingfair.net www.disneyonice.com www.downtownlawrencevillega.com #NewsPodcast #CurrentEvents #TopHeadlines #BreakingNews #PodcastDiscussion #PodcastNews #InDepthAnalysis #NewsAnalysis #PodcastTrending #WorldNews #LocalNews #GlobalNews #PodcastInsights #NewsBrief #PodcastUpdate #NewsRoundup #WeeklyNews #DailyNews #PodcastInterviews #HotTopics #PodcastOpinions #InvestigativeJournalism #BehindTheHeadlines #PodcastMedia #NewsStories #PodcastReports #JournalismMatters #PodcastPerspectives #NewsCommentary #PodcastListeners #NewsPodcastCommunity #NewsSource #PodcastCuration #WorldAffairs #PodcastUpdates #AudioNews #PodcastJournalism #EmergingStories #NewsFlash #PodcastConversations  See omnystudio.com/listener for privacy information.

In this special episode, we're in conversation with Tom Hart, President of the ONE Campaign and former Director of The Episcopal Church's Office of Government Relations. We discuss the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), the role of the faith community in the success of this program, and the urgent need for reauthorization. He will share his insights on the program and share his perspective on what steps must be taken to ensure that progress is not erased.  About PEPFAR: In 2003, President George W. Bush launched PEPFAR, elevating the prevention and treatment of HIV/AIDS as a foreign policy priority. The faith community was instrumental in the development of this program, and we have continued to play a critical role in its success. PEPFAR has saved more than 25 million lives and fundamentally changed the course of the global HIV/AIDS pandemic. PEPFAR's authorization expired on September 30, and reauthorization is needed. Tom Hart is President of the ONE Campaign. Tom has been with ONE since 2003 and most recently served as acting CEO while Gayle Smith was on leave at the U.S. State Department. Tom has years of experience in driving the fight to end extreme poverty, a deep knowledge of and experience in making change happen, and an undying commitment to ONE's mission. Prior to serving as acting CEO, Tom was the North American executive director, where he oversaw ONE's advocacy in the United States and Canada, as well as ONE's global campaign against the COVID-19 pandemic. Tom has been part of the adoption of significant initiatives to support global health, increase electrification and private sector investment in Africa, and raise billions of dollars in poverty-fighting assistance. Previously, Tom was the senior director of government relations at ONE. Before joining ONE, Tom was the director of government relations for The Episcopal Church. The Office of Government Relations aims to represent the policy priorities of The Episcopal Church to the U.S. government in Washington, D.C., and to influence policy and legislation on critical issues, highlighting the voices and experiences of Episcopalians and Anglicans globally. The office facilitates the Episcopal Public Policy Network, a grassroots network of Episcopalians engaged in the ministry of public policy advocacy. Learn more at https://www.episcopalchurch.org/ministries/office-government-relations/.  MENTIONED IN THIS PODCAST:   Take action to support PEPFAR The One Campaign The Office of Government Relations  Internship Program 

Important provisions of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) could expire due to partisan divisions, threatening a widely successful initiative; libraries take part in U.S. Banned Books Week in the face of a rising censorship movement; Slovakia holds an early parliamentary election amid concerns that pro-Russia parties will gain power; and Chinese President Xi Jinping and Syrian President ​​Bashar al-Assad announce a partnership.   Mentioned on the Podcast   Michelle Gavin, “PEPFAR at Twenty,” CFR.org   “Let Freedom Read Day,” BannedBooksWeek.org   Jonathan Masters and Will Merrow, “How Much Aid Has the U.S. Sent Ukraine? Here Are Six Charts,” CFR.org   More Perfect, WNYC Studios   The Coldest Cast in Laramie, Serial Productions   The Rewatchables, The Ringer   Peter Wehner, “The Republican Betrayal of PEPFAR,” The Atlantic   For an episode transcript and show notes, visit us at: https://www.cfr.org/podcasts/pepfar-reauthorization-struggle-banned-books-week-slovakia-democracy-test-and-more 

Gayle Smith, CEO of the ONE Campaign, served in many leadership roles in the federal government as a staunch advocate for evidence-based decision making. As Coordinator for Global COVID Response and Health Security at the U.S. Department of State in 2021, Smith led the U.S. effort to end the global pandemic, helping the Biden-Harris Administration map out a response, identify spikes, and target vulnerabilities through monitoring, testing, diagnostics, and other tools. As Administrator of the United States Agency for International Development (USAID) during the Obama Administration, Smith prioritized a culture of evaluation and learning, emphasizing the importance of focusing on outcomes rather than inputs and using data and evidence to make midcourse corrections on projects and programs. And, as a White House official who played a leading role in the U.S. response to Ebola, Smith saw firsthand the importance of leveraging data to track outbreaks, target treatments, invest resources, and move in real time to maximize impact. On this episode of Mathematica's On the Evidence podcast—one in our occasional Evidence in Government series—Mike Burns, Mathematica senior director of communications and public affairs, spoke with Smith about a range of topics including evaluation at USAID, the U.S. response to Ebola, the intersection of development finance and climate change, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), bilateral and global agencies, and the COVID-19 global health crisis, including its economic impact on women. A full transcript of this episode is available here: https://www.mathematica.org/blogs/gayle-smith-on-the-federal-role-in-global-response-to-health-and-climate-crises Read Smith's remarks from the 2016 Brookings Institution event on the state of evaluation at USAID: https://www.brookings.edu/wp-content/uploads/2016/03/20160330_usaid_evaluation_transcript.pdf Read the ONE Campaign's statement on the appointment of Ajay Banga as president of the World Bank: https://www.one.org/us/press/banga-world-bank/ Read ONE's statement on the 20th anniversary of the PEPFAR announcement: https://www.one.org/us/press/one-statement-on-20th-anniversary-of-pepfar-announcement/ Read Smith's POLITICO interview with Ambassador Linda Thomas-Greenfield: https://www.politico.com/news/magazine/2022/11/01/linda-thomas-greenfield-gayle-smith-interview-00014844

Twenty years ago, the U.S. launched the largest, most successful global health initiative to ever address a single disease. The President's Emergency Plan for AIDS Relief (PEPFAR) is credited with saving at least 20 million lives. New York Times columnist Nick Kristof recently called PEPFAR “the single best policy of any president in my lifetime.”By early 2002, HIV/AIDS was devastating sub-Saharan Africa. Josh Bolten, then-Deputy Chief of Staff for Policy, assembled a team to investigate how a U.S.-led fund could help stop the epidemic. The team included our guest today, Dr. Mark Dybul.Dybul later served as the U.S. Global AIDS Coordinator, leading PEPFAR from 2006 until the end of the Bush administration. Dybul was the Executive Director of the Global Fund to Fight AIDS, Tuberculosis, and Malaria from 2013-2017.(00:00) Introduction(14:49) Trials in the field(31:00) Political coverage(37:17) Fights within the U.S. government(43:22) The president steps in(51:39) Involving Congress This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.statecraft.pub

Welcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio. This is: Did Economists Really Get Africa's AIDS Epidemic "Analytically Wrong"? (A Reply), published by TomDrake on August 30, 2023 on The Effective Altruism Forum. To demonstrate CGD's cherished principle of not taking organisation positions, here is a response from a couple of us in the health team to our colleague Justin Sandefur's recent(ish) blog on cost-effectiveness evidence and PEPFAR. Our concern was that readers might come away from Justin's blog thinking that cost-effectiveness evidence wasn't useful in the original PEPFAR decision and wouldn't be useful in similar decisions about major global health initiatives. We disagree and wanted to make the case for cost-effectiveness as well as addressing some of Justin's specific points along the way. A recent, thought-provoking blog by our colleague, Justin Sandefur, titled "How Economists got Africa's AIDS Epidemic Wrong", has sparked a debate about the historical role of cost-effectiveness analysis in assessing the investments of the President's Emergency Plan for AIDS Relief (PEPFAR) and, implicitly, the value of such analysis in making similar global health decisions. Justin tells the story of PEPFAR and concludes that economists that raised concerns over the cost-effectiveness of antiretroviral therapies got PEPFAR "analytically wrong", a conclusion that some readers may interpret as a reason to discard cost-effectiveness analysis for such decisions in the future. The original blog draws three lessons: Lesson #1. What persuaded the White House was evidence of feasibility and efficacy, not cost-effectiveness Lesson #2. The budget constraint wasn't fixed; PEPFAR unlocked new money Lesson #3. Prices also weren't fixed, and PEPFAR may have helped bring them down In this blog we argue that while Justin's observations hold some truth, they do not discredit the value of cost-effectiveness analysis in decision-making. Specifically, we contend that: Because there were many feasible and effective options at the time, this was not sufficient criteria for such a large decision. It should have considered the cost-effectiveness of other options, to explore the relative impact. PEPFAR may have unlocked some new money, but it wasn't all new money, and it will have had short- and long-term opportunity costs. Moreover we cannot be certain that PEPFAR was uniquely able to increase available funding. Thus the decision could have considered cost-effectiveness analysis to reveal likely trade-offs. Price reductions could have been analytically explored for PEPFAR and for alternative options as part of cost-effectiveness analysis during decision-making. The bigger lesson, we conclude, is that when the next PEPFAR-sized decision happens, our systems and their stakeholders must strive for higher standards, embracing analysis that models a range of good options and assesses them against key criteria. Cost-effectiveness analysis is a necessary component of this, but it is not sufficient, and additional analysis and scenarios should be considered through a deliberative process, before settling on a final decision. Below we offer reflections on each of Justin's three lessons, in order, then draw out the overall conclusions. Response 1: Feasibility and efficacy are not enough Justin uses an analogy of giving to a homeless person to invite the reader to agree that cost is not really the relevant issue when considering whether to do a good deed. True enough, if something can be considered not effective or not feasible then it's a non-starter and we don't need to trouble ourselves over cost or cost-effectiveness. But when there are multiple feasible and effective options with different levels of effectiveness and cost, understanding which does the most good for the money is absolutely worth knowing. Indeed we agree that there is a moral imperative to...

The new documentary “The Deepest Breath” tells how Stephen Keenan  died six years ago while trying to rescue fellow freediver Alessia Zecchini.  Special Counsel Jack Smith today indicted Donald Trump for alleged conspiracy to overturn the 2020 presidential election and his role leading up to the Capitol insurrection. Congressional Republicans are threatening to torpedo the President's Emergency Plan for AIDS Relief (PEPFAR). It's one of President George W. Bush's greatest achievements.  The U.S. Women's National Soccer Team is now in the final 16 of this year's World Cup. But the usually dominant squad is looking shakier than most people expected. Concertgoers have been increasingly throwing objects at performers while they're on stage. Why? Blame “main character syndrome.”

Gary Edson, Covid Collaborative, reflects on the President's Emergency Plan for AIDS Relief (PEPFAR), now at its 20th anniversary. It originated with a Republican president, George W. Bush, who transformed development assistance. Bipartisanship was vital, and PEPFAR fulfilled moral and geostrategic goals. Now, PEPFAR reauthorization is in peril in the post-Dobbs era. What needs to happen to rescue things? In the toxic, polarized post-Covid era, how do we step over that noise and bring about a new conversation about topline goals to protect Americans on a bipartisan basis? Give a listen!

Sheryl Gay Stolberg, NYT national correspondent on health and politics, unpacks the post-Dobbs era: does it imperil or boost the right to contraception? Or both? Does it put the President's Emergency Plan for AIDS Relief (PEPFAR) under new scrutiny? Calls to “take a fresh look” at PEPFAR may signal trouble. “Abortion politics is laying over all of our conversations” in this “super-partisan era.” In the post-Covid era, the reporting environment has loosened. Why is it that filling the US leadership gap in science and health is moving along so slowly? What should we make of RFK Jr's arrival on the scene, a figure in the larger campaign to vilify Dr. Anthony Fauci? What can we expect in the coming battles over Medicare drug pricing following the Inflation Reduction Act? 

In this episode, Sujani sits down with Dr. Marissa Robinson, coordinator of the Ending the HIV Epidemic initiative at the US Department of Health. They discuss Marissa's education and career, her interest in HIV and the Black community's access to health, and harnessing charisma in your professional life. You'll LearnHow Marissa's personal experiences shaped her interest in the social determinants of health, specifically with HIV and the Black community's access to healthMarissa's experience at Spelman College, a historically Black college for women, and what factors she considered when making choices about educationTips on dealing with rejection, self doubt, and other barriers in your careerHow charisma is essential in leadership and public health and why it is especially important for women of colour to develop this skillToday's GuestDr. Marissa Robinson is a strategic-leader, visionary, and disruptor within the field of Infectious Disease. She focuses on HIV/AIDS research, educating the need to increase opportunities and diversity amongst the public health workforce. She currently leads as the Ending the HIV Epidemic in the U.S. (EHE) initiative Coordinator at the US Department of Health and Human Services (HHS) Office of the Assistant Secretary for Health within the Office of Infectious Disease and HIV/AIDS Policy.Dr. Robinson is a DMV native and is trained in infectious disease epidemiology. She has conducted extensive HIV/AIDS research for over a decade. She began her federal career when she joined the United States Peace Corps as a Community Health and Malaria Prevention volunteer in Togo, West Africa. After returning to the US, Dr. Robinson worked at the Health Resources and Services Administration (HRSA) in the HIV/AIDS Bureau (HAB) on global infectious disease surveillance supporting the President's Emergency Plan for AIDS Relief (PEPFAR) initiative. Following her time at HRSA, Dr. Robinson joined the Centers for Disease Control and Prevention (CDC) where she conducted and maintained data analytics for a Nursing and Midwifery initiative on behalf of PEPFAR for 13 African countries. After her time at CDC, Dr. Robinson joined the CDC Foundation on the Teens Linked to Care pilot program with the CDC's Division of Adolescent and School Health which focused on substance use and sexual risk among youth in rural populations.Dr. Robinson completed her Doctor of Public Health degree as a Goldseeker Scholar at Morgan State University's School of Community Health and Policy. Her dissertation was entitled “A Qualitative Exploration of Preexposure Prophylaxis Among Black Women Attending a Historically Black College and University in the Northeastern United States”. Dr. Robinson completed her doctoral fellowship training at Johns Hopkins School of Medicine Pre-Doctoral Clinical Research Training Program. Dr. Robinson received her Master of Public Health with a concentration in global health, infectious diseases, and a certificate in socio-contextual determinants of health from Emory University's Rollins School of Public Health and her Bachelor of Arts in psychology and public health from Spelman College.ResourcesFollow Marissa on LinkedIn or Twitter or send her an email Learn more about Spelman College Listen to The "It" FactorSupport the showJoin The Public Health Career Club: the #1 hangout spot and community dedicated to building and growing your dream public health career.

In this interview, Cynthia Changyit Levin, a mom, author, and member of the ONE Campaign, discusses her upcoming trip to Capitol Hill to advocate for support for the President's Emergency Plan for AIDS Relief (PEPFAR). She highlights the importance of bipartisan efforts to fight against AIDS and shares the need to re-energize people's attention to this ongoing issue. Cynthia also expresses her concerns about funding and the potential consequences of neglecting the fight against HIV/AIDS. The interview sheds light on the impact of AIDS on marginalized communities and emphasizes the significance of grassroots activism.

Tim Scott, U.S. Senator from South Carolina, discusses the latest on the debt ceiling negotiations and how the President's Emergency Plan for AIDS Relief (PEPFAR) reauthorization is being used as a vehicle to push woke ideologies on countries desperate for resources to fight HIV/AIDS. Mark Alford, U.S. Representative for the 4th District of Missouri, comments on the Navy's drag queen influencer and news that the Marine Corps is deactivating its formerly women-only recruit battalion at Parris Island. Gary Palmer, U.S. Representative for the 6th District of Alabama, reacts to allegations of a pay-to-play scheme then-Vice President Joe Biden was involved in. Jody Hice, former congressman and FRC's Senior Advisor to the President, highlights the National Day of Prayer and shines a light on further alleged Biden family schemes. --- Support this podcast: https://podcasters.spotify.com/pod/show/loving-liberty/support

20 years ago, as HIV and AIDS threatened vast populations in sub-Saharan Africa, Haiti, Guyana and Vietnam, the US Government made the largest investment in battling a pandemic. Known as the President's Emergency Plan for AIDS Relief (PEPFAR).  May 27th marked the 20th anniversary of the creation of this bipartisan program which coordinated the work of government agencies and local governments to reduce the infections. Dr. Deborah Birx, who had a significant role in the program visits The Common Bridge to talk about PEPFAR's renewal.  Don't be surprised when the discussion takes a turn to more current events. In part 2, Dr. Birx responds to Rich's questions about the decline in scientific credibility.Support the showEngage the conversation on Substack at The Common Bridge!

With recently passed anti-LGBT legislation in Uganda, Eric and Ben discuss what role global health diplomacy could play (and most likely was) in upholding human rights and ensuring that essential HIV-related services reach those most in need - especially LGBT communities. And we answer your questions, second episode in. About the hosts: Eric Goosby is an American public health official and professor at UCSF, where he directs the Center for Global Health Delivery and Diplomacy. An infectious disease specialist, he treated patients at San Francisco General Hospital when HIV/AIDS first began to emerge and take its toll in the early 1980s.  Eric joined the Clinton administration to administer newly-authorized Ryan White CARE Act, overseeing the distribution of federal funds and the planning of services in 25 AIDS epicenters, as well as in all 50 states and U.S. territories. He went on to co-found the Pangaea Global AIDS Foundation, where he helped develop and implement HIV national treatment scale-up plans in Rwanda, South Africa, China, and Ukraine. In 2009, he was tapped by President Obama to be his Global AIDS Coordinator, heading up the President's Emergency Plan for AIDS Relief (PEPFAR), a position he held until 2013. He went on to be the UN Special Envoy on Tuberculosis. Eric likes very strong coffee, and is being educated by Ben on the joys of podcasting. Ben Plumley is a global health strategist, currently the Head of Digital Advocacy and Outreach at the Global Health Listening Project, and founder of the Global Health Strategy Agency, Hunuvat. He was Chief of Staff to the Founding Executive Director of UNAIDS, and Executive Director of the Global Business Coalition on HIV & AIDS.  He held senior roles in Glaxo Wellcome and Johnson & Johnson. In 2010, he was appointed CEO of the Pangaea Global AIDS Foundation, succeeding Eric Goosby, where he advised national governments, corporations, the UN and community organizations on infectious disease treatment and prevention strategies in Zimbabwe, Nigeria, China, Ukraine, Laos and South Africa. He is Co-Chair of the MTV Staying Alive Foundation, and President of the San Francisco Community Health Center. His journey into podcasting began in 2018 with A Shot In The Arm Podcast. Eric has been a mentor to Ben since the early 2000s, including his passion for exceptionally strong coffee.

On today's program: Tim Scott, U.S. Senator from South Carolina, discusses the latest on the debt ceiling negotiations and how the President's Emergency Plan for AIDS Relief (PEPFAR) reauthorization is being used as a vehicle to push woke ideologies

Ambassador Dr. John N. Nkengasong, Ph.D. ( https://www.state.gov/biographies/john-n-nkengasong/ ), is U.S. Global AIDS Coordinator and Special Representative for Health Diplomacy, a position he was officially sworn in on June 13, 2022, where he leads, manages, and oversees the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). PEPFAR is the largest commitment by any nation to address a single disease in history, prevent millions of HIV infections, save lives, and make progress toward ending the HIV/AIDS pandemic. Born in Cameroon, Dr. Nkengasong is the first person of African origin to hold this position. In 2017, Dr. Nkengasong was appointed as the first Director of the Africa Centers for Disease Control and Prevention (Africa CDC) headquartered in Addis Ababa, Ethiopia. Through his leadership, a framework for moving Africa CDC into a full autonomous health agency of the Africa Union was established. Dr. Nkengasong led efforts to create policy frameworks to guide countries to establish and strengthen their public health institutes and defined and implemented a system to collate national surveillance data. He also led the COVID-19 response in Africa, coordinating with heads of state and governments across the continent, and among other achievements to fight the COVID-19 pandemic, he helped secure 400 million doses of COVID-19 vaccines at the height of vaccine scarcity. During his tenure, he was appointed as one of the World Health Organization's special envoys on COVID-19 preparedness and response. Dr. Nkengasong served as the U.S. Centers for Disease Control and Prevention (CDC) Division of Global HIV and Tuberculosis' International Laboratory Branch Chief and as the Associate Director for Laboratory Science. Subsequently, he served as Acting Deputy Director at the CDC Center for Global Health and Co-Chair of the PEPFAR's Laboratory Technical Working Group. As a leading virologist with over 30 years of experience in public health, Dr. Nkengasong was appointed as a board member for the International AIDS Vaccine Initiative in New York, and the Coalition for Epidemic Preparedness Innovation, in Norway. Dr. Nkengasong received his B.Sc. from the Faculty of Science, University of Yaoundé, Cameroon; his M.Sc. from the Institute of Tropical Medicine, Antwerp, Belgium; and his Ph.D. from the Faculty of Medicine, University of Brussels, Belgium. He also received a Diploma in Leadership and Management from the Kennedy School of Government at Harvard University. Dr. Nkengasong is the recipient of numerous prestigious awards and recognitions. Most recently, he served as one of the World Health Organization Director General's Special Envoys for COVID-19. In 2021, Dr. Nkengasong was recognized as Time Magazine's 100 Most Influential People, where he was described as “a modern-day hero.” Additional awards include the U.S. Secretary of Health and Human Services Award for excellence in Public Health Protection Research, the Shepard Award, the U.S. Director's Recognitions Award and the William Watson Medal of Excellence, the highest recognition awarded by CDC; which was awarded for outstanding contributions and leadership in advancing global laboratory services and programs to support the PEPFAR. Most recently, Dr. Nkengasong was invited to become a member of the National Academy of Medicine and he became the first-ever laureate of the Virchow Prize for Global Health, for his dedication to improving the health and wellbeing of the world's most vulnerable people. He has authored or co-authored over 250 peer-reviewed papers and book chapters in professional journals. Support the show

In the series premiere of “Global Health Diplomats”, Eric Goosby and Ben Plumley explore the continuing saga of the origins of SARS CoV2 and the role of global health diplomacy in fostering international collaboration in fighting pandemics threats - and who better to discuss this with than our first guest, Dr. Anthony Fauci, the recently retired director of the National Institute of Allergy & Infectious Disease. -- About the hosts: Eric Goosby is an American public health official and professor at UCSF, where he directs the Center for Global Health Delivery and Diplomacy. An infectious disease specialist, he treated patients at San Francisco General Hospital when HIV/AIDS first began to emerge and take its toll in the early 1980s.  Eric joined the Clinton administration to administer newly-authorized Ryan White CARE Act, overseeing the distribution of federal funds and the planning of services in 25 AIDS epicenters, as well as in all 50 states and U.S. territories. He went on to co-found the Pangaea Global AIDS Foundation, where he helped develop and implement HIV national treatment scale-up plans in Rwanda, South Africa, China, and Ukraine. In 2009, he was tapped by President Obama to be his Global AIDS Coordinator, heading up the President's Emergency Plan for AIDS Relief (PEPFAR), a position he held until 2013. He went on to be the UN Special Envoy on Tuberculosis. Eric likes very strong coffee, and is being educated by Ben on the joys of podcasting. Ben Plumley is a global health strategist, currently the Head of Digital Advocacy and Outreach at the Global Health Listening Project, and founder of the Global Health Strategy Agency, Hunuvat. He was Chief of Staff to the Founding Executive Director of UNAIDS, and Executive Director of the Global Business Coalition on HIV & AIDS.  He held senior roles in Glaxo Wellcome and Johnson & Johnson. In 2010, he was appointed CEO of the Pangaea Global AIDS Foundation, succeeding Eric Goosby, where he advised national governments, corporations, the UN and community organizations on infectious disease treatment and prevention strategies in Zimbabwe, Nigeria, China, Ukraine, Laos and South Africa. He is Co-Chair of the MTV Staying Alive Foundation, and President of the San Francisco Community Health Center. His journey into podcasting began in 2018 with A Shot In The Arm Podcast. Eric has been a mentor to Ben since the early 2000s, including his passion for exceptionally strong coffee.

Friday marks one year since the Russian invasion of Ukraine. U.S. Secretary of State Antony Blinken joins "CBS Mornings" to discuss the ongoing war and the increasing global tensions between world powers.This year marks 20 years since then-President George W. Bush enacted the President's Emergency Plan for AIDS Relief (PEPFAR) to fight the HIV/AIDS epidemic. Dr. Deborah Birx served as the U.S. Global AIDS Coordinator, implementing PEPFAR programs around the world. She joins "CBS Mornings" to discuss where we stand in the fight against HIV/AIDS and what work stills needs to be done.Actor Eugene Levy joins "CBS Mornings" for a closer look at his new Apple TV+ series, "The Reluctant Traveler," and whether a "Schitt's Creek" movie could be happening in the near future.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

President George W. Bush joined 66th U.S. Secretary of State Dr. Condoleezza Rice and Former President of the United Republic of Tanzania Dr. Jakaya Mrisho Kikwete  for a conversation during PEPFAR at 20, an event marking 20 years of the President's Emergency Plan for AIDS Relief (PEPFAR) hosted by the George W. Bush Institute. The trio discussed the inception of PEPFAR, its enormous impact, and how the program is a win for both partner countries and for U.S. foreign policy. Related:Pepfar at 20 eventA report series on lessons learned from PEPFAR's successRead: Building on PEPFAR's success: Is a win for U.S. foreign policy

The power of NMF is its ability to empower and uplift the next generation of healthcare leaders. Listen to how Carmen Villar, Vice President of Social Business Innovation at Merck & Co is #reimagininghealthcar by elevating the intersection of social and business impact while striving to create sustainable health systems to support improved health and well-being globally.  Prior to joining Merck, Carmen was Chief of Staff at the Centers for Disease Control and Prevention (CDC). Carmen led the agency through both the West African Ebola and the Zika emergency responses. Her leadership was critical in providing coordination across the agency and with other US government counterparts and earned her the honor of the Presidential Meritorious Rank Award. She worked in both Nigeria and Zambia, providing leadership and oversight to CDC's programs as part of the President's Emergency Plan for AIDS Relief (PEPFAR). As a key health advisor to the US Ambassadors in Nigeria and Zambia, she also provided expert advice in critical public health areas such as Polio and Tuberculosis.  Carmen started in government as a Presidential Management Fellow focusing on policy and program planning for HIV, STD, and TB prevention. Carmen has also overseen multi-site domestic and international HIV research projects in the areas of drug use, prevention of mother-to-child treatment, and vaccines. Prior to joining the CDC, she was the Policy Affairs Coordinator at the AIDS Healthcare Foundation and had also served as a Legislative Aide in the California Assembly. Carmen holds a Master's in Social Welfare from UC Berkeley and a Bachelor's in Anthropology from UC Berkley. She is currently a Board Member of NMF. National Medical Fellowships, Inc. believes a just and equitable world requires diverse healthcare leaders who not only bring diverse representation to the medical field but also lead the fight to eliminate health disparities.  You can learn more about NMF at www.nmfonline.org

December 1 is World AIDS Day, and January 2023 marks 20 years of the President's Emergency Plan for AIDS Relief (PEPFAR), which provides for groundbreaking AIDS treatment, prevention, and research. In this episode of Big World, SIS dean Shannon Hader, an expert in infectious diseases and epidemiology and a global leader in the fight against HIV/AIDS, joins us to explore how the AIDS response informed policies during the outbreak of COVID-19 and how politics impacts the public perception of public health crises. Dean Hader discusses how PEPFAR's monumental achievements have influenced public health policy (3:22) and how PEPFAR continues to garner bipartisan, bicameral support from Congress, even throughout a time of intense political division (5:43). She explains how blame and shame are not sustainable or effective responses to an infectious disease (11:30). She also talks about the dangers of putting the goals of disease prevention and treatment in opposition to one another (13:23). How did the HIV community respond to the emergence of the COVID-19 virus (17:07)? While with UNAIDS, how did Hader help advise public health officials on how to protect human rights amid a crisis (18:51)? Hader answers these questions and discusses the importance of data in making sound decisions and targeting resources (21:01). The episode concludes as Hader shares how her impressive career in public health prepared her to lead a top-10 international relations school (27:17) and what she hopes to accomplish while at SIS (31:20). During our “Take Five” segment, Hader shares the five steps she would recommend to governments around the world to create and sustain positive forward momentum on AIDS research, prevention, and treatment (22:29).

On this episode of CareTalk, we take a look back at the illustrious career of Dr. Anthony Fauci. Throughout his over 50 years in public service, Dr. Fauci has made countless contributions to the fields of medicine and public health. He played a key role in the development of the AIDS prevention strategy known as "Treatment as Prevention," and he was instrumental in the creation of the President's Emergency Plan for AIDS Relief (PEPFAR). In addition, he has served as the Director of the National Institute of Allergy and Infectious Diseases (NIAID) since 1984, leading groundbreaking research on HIV/AIDS, influenza, and other infectious diseases. Dr. Fauci's tireless dedication to his work has saved countless lives and made him a household name. On this special episode of CareTalk, we pay tribute to one of the greatest public servants of our time.ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.GET IN TOUCHBecome a CareTalk sponsorGuest appearance requestsVisit us on the webFOLLOW CARETALKSpotifyApple PodcastsGoogle PodcastsFollow us on LinkedIn#healthcare #healthcarepodcast #healthcareindustry #healthcarebusiness #publichealth #anthonyfauci

Dr. Deborah Birx was drawn to science from a very young age. Along with her siblings, and with the full support of her parents, Dr. Birx soldered circuit boards, searched for fossils, and recorded measurements of solar eclipses while other kids her age colored and played hopscotch. Her early scientific exploration led Dr. Birx to study chemistry in college, where she became fascinated by infectious diseases. That fascination led her to medical school, the bedside, the lab, and eventually a 40+ year career as a public health servant. Throughout her career, Dr. Birx looked to the data for guidance. The data, she tells us, helps you to understand what is going on. From there, Dr. Birx adds, you've got to act. First, by planning your response, and second, by implementing your solution in the community. Dr. Birx tells us the second part is often lacking in the U.S. – “sometimes people in public health forget the first word is public and it really means population. And you have to work with everybody in the public and everybody in the population. So, stop making excuses, stop blaming it on people and fix it.” On this episode, we explore Dr. Birx's path from childhood scientist, to practicing physician, researcher, director of CDC's Division of Global HIV/AIDS (DGHA),  Ambassador-at-Large, and U.S. Global AIDS Coordinator as part of the President's Emergency Plan for AIDS Relief (PEPFAR) program, and White House Coronavirus Response Coordinator under President Donald Trump (and believe it or not, still much more in-between!). We also discuss how there are 21st-century tools that are available today that can drastically change our experience with infectious disease and why we are not using them. Dr. Birx tells us “We don't have to accept in the 21st century that we continue to succumb to infectious diseases”. For full show notes and links, visit https://deepdive.tips/ ... Dr. Deborah Birx will be the keynote speaker at the upcoming GBAC Symposium on Air Considerations in Chicago on August 16 and 17, 2022. The Symposium is focused on improving the quality of indoor air in non-healthcare settings. Dr. Birx will talk about that in the context of COVID, and Monkey Pox, outlining effective innovations that are available for use today.

Dr. Paul Zeitz has been an activist for Social Justice before the term was widely known. His forward thinking and optimism led him to becoming a major part of the advocacy efforts that established global programs to combat AIDS, TB, and Malaria. He spearheaded advocacy for the President's Emergency Plan for AIDS Relief (PEPFAR), including advocacy to ensure an annual budget of $5 Billion. After nearly 20 years, PEPFAR is responsible for saving the lives of 40 million people. Dr. Zeitz served as a Director at the US Department of State where he catalyzed the formation of the Global Partnership For Sustainable Development Data which has hundreds of partners solving the issues of Social, economic, environmental, racial, and gender justice. His work has been endorsed by major figures including Alicia Keys, Archbishop Desmond Tutu, and Dr. Tedros Adhanom Ghebreyesus (Director General of the World Health Organization).

Sometime in 2021, I had the rare opportunity of visiting the Institute of Human Virology Nigeria (IHVN)Institute of Human Virology Nigeria (IHVN) was established in 2004 as an affiliate of the Institute of Human Virology, University of Maryland School of Medicine. It was incorporated in March 2004 as a local non-governmental organization with a Board of Directors. PicturesHowever, the inception of IHVN started with Dr. William Blattner and Dr. Alash'le Abimiku, both working at the National Institute's of Health and conducting early studies to track the emerging HIV epidemic in Nigeria. In 1995, Dr. Blattner in partnership with Dr. Robert C. Gallo and Dr. Robert Redfield  co-founded Institute of Human Virology (IHV), University of Maryland School of Medicine, Baltimore. Drs. Blattner and Abimiku successfully competed for international funding from the US Military, the Bill and Melinda Gates Foundation and the Centers for Disease Control (CDC) AIDS Program for a University Technical Assistance Program (UTAP) award to support the establishment and growth of IHVN.  Since 2004, the US President's Emergency Plan for AIDS Relief (PEPFAR) has supported the AIDS Care and Treatment in Nigeria (ACTION) project and follow-on grants, ACTION Plus, ACTION PlusUp and Action to Control HIV Epidemic through Evidence (ACHIEVE) projects.  http://ihvnigeria.org/about-us/our-history/I had an amazing time with the Chief Executive Office, Dr. Patrick Dakum who gave me a detailed mind tour of the organization on what they do and their economic importance.Take a listen   Support the show

In this episode, CSIS Senior Associate Jeffrey L. Sturchio speaks with author Emily Bass about her new book, To End a Plague, which chronicles the transnational activism, legislative deal-making, and unprecedented political leadership that led to President George W. Bush's 2003 announcement of the U. S. President's Emergency Program for AIDS Relief (PEPFAR). With more than $85 billion invested, 18.2 million men, women, and children treated with antiretroviral therapy, and more than 50 million people provided HIV prevention services in recent years, it is also the largest commitment in history by any nation to address a single disease.  In this conversation, Bass reflects on what drew her to this complex and compelling story, on the key factors in PEPFAR's origins and evolution, on the reasons for the program's improbable and long-standing bipartisan support, and on the crucial contributions of people living with HIV/AIDS and their allies and advocates in shaping the program's priorities. She also comments on the role of the private sector and on lessons to be learned from PEPFAR in the present moment, when the world continues to grapple with the Covid-19 pandemic.

Dr. Birx, former Response Coordinator during the Trump administration of the White House Covid-19 Task Force, served also as the Global Health Ambassador and Coordinator of the President's Emergency Plan for AIDS Relief (PEPFAR) between April 2014 and January 2021. She joined us for an extended conversation on the accelerating changes surrounding us – the Delta variant surge, new discoveries regarding breakthrough infections among the vaccinated, continued vaccine hesitancy, and refusal that has prompted the declaration of “a pandemic of the unvaccinated.” As we speak, newly revised policies on masks and vaccinations are getting unveiled. What to make of this new phase, and where is it heading? We'll need far higher testing and genomic sequencing, intensified local engagement, a big push on accelerating therapies, and thinking ahead on what the future mix of vaccines will look like.  Dr. Deborah Birx is a Senior Fellow at the George W. Bush Presidential Center

#DidYouKnow: Prevention of Tuberculosis in People Living with HIV requires prevention interventions for both HIV infection and TB. This includes HIV counseling, testing, disclosure, partner testing and behavior modification to mention a few. Rumbidzai Venge speaks to Dr. Rachel Weber, HIV Services Branch Chief, CDC Zimbabwe and Dr. Blessing Mushangwe, Senior Program Manager, Zim-TTECH. Follow the conversation as they discuss preventing TB among people living with HIV in Zimbabwe. Courtesy of The U.S. President's Emergency Plan for AIDS Relief (PEPFAR)

We discussed a number of things including: 1. Richard's background and his impact on population health worldwide 2. Progress on the COVID-19 response - vaccines and treatments 3. Concerns about inequity in relation to the pandemic 4. Programs that are addressing these challenges Since the beginning of the AIDS epidemic, Richard Marlink, MD, has worked to establish HIV/AIDS research, training, and clinical care programs in the United States and abroad. He was instrumental in setting up the first HIV/AIDS clinic in Boston, and in the mid-1980s in Senegal, he was part of the team of Senegalese, French, and American researchers who discovered evidence for and then studied the disease outcomes of the second type of human AIDS virus, HIV-2. Previously at Harvard, Marlink helped create two partnerships with the government of Botswana: the 1996 Botswana-Harvard Partnership with the Harvard AIDS Initiative, where he was executive director, and the African Comprehensive HIV/AIDS Partnerships, a public-private partnership with the government of Botswana that was launched in 2000 with funding from the Bill and Melinda Gates and Merck foundations. Also in 2000, Marlink founded the Kitso AIDS Training Program, which would become Botswana's national AIDS training program. Kitso means “knowledge” in the local Setswana language. Marlink was the principal investigator for “The Tshepo Study,” the first large-scale antiretroviral treatment study in southern Africa, funded by the Bristol-Myers Squibb Foundation's Secure the Future initiative. His research in the region also includes clinical and epidemiological evaluations to help determine how antiretroviral treatment and national treatment programs can best be accomplished in Africa. Since 2000, programs he has created and/or led have trained tens of thousands of health care workers and helped establish national programs on the care, treatment, and prevention of HIV/AIDS in several African countries. Following the 2003 launch of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) to combat global HIV/AIDS, the largest commitment by any nation to combat a single disease in history, Marlink was Botswana's country director for the Botswana-Harvard PEPFAR effort. In addition, while serving as scientific director and vice president for implementation at the Elizabeth Glaser Pediatric AIDS Foundation, he was principal investigator of Project HEART, another PEPFAR Track 1.0 effort in five African countries. Project HEART began in 2004 and by 2011 had placed more than one million people living with HIV into clinical care sites in Cote d'Ivoire, Mozambique, South Africa, Tanzania, and Zambia. More than 565,000 were placed on life-saving antiretroviral treatment.

Bill Frist is a nationally acclaimed heart and lung transplant surgeon, former U.S. Senate Majority Leader, and is actively engaged in health policy and education reform. In this episode, Bill takes us through his long and varied career in medicine, politics, and business, which includes establishing the organ transplantation program at Vanderbilt as well as rising from the lowest-ranked member of the U.S. Senate to the Majority Leader in two terms. We discuss some of the most significant moments of his time in the Senate, such as advocating for AIDS prevention programs' funding and addressing complicated issues like stem cell research and the end-of-life issues raised by the Terri Schiavo case. We also hear his first-person account of what happened behind the scenes on September 11, 2001, his frustration with our lack of preparation for the pandemic, and his thoughts about the current state of U.S. politics. Finally, we talk about his current endeavors in health policy and education reform. We discuss: Bill’s decision to pursue medicine and do organ transplants (3:40); The miraculous nature of organ transplants: History, Bill’s work, and the most exciting things to come (12:00); Frist’s experience building up the heart transplant program at Vanderbilt (21:45); The famous rivalry between surgeons Denton Cooley and Michael DeBakey (29:15); How the medical field can attract bright young people to pursue medicine (33:00); Bill’s decision to leave medicine and run for the US senate (38:00); The value in having scientists and physicians in Congress (47:30); A discussion on whether or not senators should have term limits (55:30); The highly polarized nature of politics, and how we can fix it with empathy (1:00:30); Bill’s time in the Senate and quick rise to Senate Majority Leader (1:05:30); The lifesaving impact of the President's Emergency Plan for AIDS Relief (PEPFAR) under George W. Bush (1:15:15); How Bill reversed course on his view of the value and morality of stem cell research (1:19:45); Complex end-of-life decisions, and Bill’s role in the infamous Terri Schiavo case—a story that captures the conflict among law, morality, and improving technology (1:30:00); Remembering the events of September 11th from Bill’s perspective in the Senate (1:49:45); The coronavirus pandemic: Bill’s accurate 2005 prediction, and a discussion about future preparedness (1:56:45); The divided state of US politics, and how we can come together (2:06:45); How experience in medicine and politics is shaping Bill’s current endeavors in business, reforming education, palliative care, and more (2:12:45); and More. Learn more: https://peterattiamd.com/   Show notes page for this episode: https://peterattiamd.com/BillFrist    Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/   Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/   Connect with Peter on Facebook | Twitter | Instagram.

Tune into this episode as co-host, Stephanie Whitehead, and special guests, Tiffany Channer and Aaron Odegard, discuss the importance of joining a professional organization.  If you are a laboratory professional looking to jump start your career or get more involved in your profession, this is the episode for you! Key takeaways: Learn about the personal and professional benefits you will gain from joining professional organizations.  Understand the benefits of being actively involved in a professional organization Learn about volunteer opportunities and committees that support the laboratory profession  Special Guest Bios:Aaron Odegard serves as the current Chair of the ASCP Council of Laboratory Professionals.  He enjoys educating the public, medical laboratory science students and professionals on the topics of antimicrobial resistance and stewardship through many platforms including: classrooms, local and regional meetings, and social media. Aaron can be reached on LinkedIn at “Aaron Odegard”.Tiffany Channer is the assistant administrative director of Laboratories and quality manager at White Plains Hospital (WPH). Prior to joining WPH, Ms. Channer worked for 9 years at Memorial Sloan Kettering Cancer Center (MSKCC) in New York, NY as lead medical technologist III/ safety officer, where she honed her skills in blood banking and transfusion medicine. In Ms. Channer's spare time, she supports her passion for community service, laboratory science, and public health by conducting presentations at local high schools, educating students on the importance of an education and correlating epidemiological theory and statistics into the clinical laboratory setting. Ms. Channer also served as American Society Clinical Pathology (ASCP) / President Emergency Plan for AIDS Relief (PEPFAR) initiative consultant in Swaziland, Africa. Additionally, she has served as the ASCP Chair for the Council of Laboratory Professionals, Patient Champion Advisory Board Member, and Career Ambassador. Tiffany can be reached on LinkedIn at “Tiffany Channer”. Be a Supporter! Listen on Direct Impact Broad Casting, Spotify, Apple Podcast or your favorite podcast platform. Don't forget to subscribe to the show on your phone, tablet or notebook so you never miss an episode! Be sure to leave a comment, and share with a fellow medical laboratory professionals!Be a Guest!  If you have a leadership or laboratory message to share and would like to be a guest on the show, please reach out to us at elaboratetopics@directimpactbroadcasting.com or connect with us on Direct Impact Broadcasting through Social Media.

Join us for a rare visit with one of America's most trusted medical figures and leading experts on infectious disease, and take advantage of this unique opportunity to ask your questions directly. Dr. Fauci was appointed director of NIAID in 1984. He oversees an extensive portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases including HIV/AIDS, respiratory infections, tuberculosis and malaria as well as emerging diseases such as Ebola and Zika....and of course, COVID 19. He has advised six presidents on domestic and global health issues. He was one of the principal architects of the President's Emergency Plan for AIDS Relief (PEPFAR), a program that has saved millions of lives throughout the developing world. Dr. Fauci is the recipient of numerous prestigious awards, including the Presidential Medal of Freedom (the highest honor given to a civilian by the president of the United States) and the National Medal of Science. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Anti-Prostitution Loyalty Oath (APLO) is a provision that prevents foreign NGOs and international affiliates of U.S. organizations from using the President's Emergency Fund for AIDS Relief (PEPFAR) funds in a way that “promotes prostitution or sex trafficking” and they must have an explicit policy opposing prostitution and sex trafficking. Keifer Buckingham, Senior Policy Advisor with the Open Society Foundations and Open Society Policy Center sits down to talk with us about how the recent Supreme Court ruling that protects APLO is ultimately stigmatizing, discriminatory, and harmful to the goal of fighting HIV/AIDS. Support the show (https://www.reprosfightback.com/take-action#donate)

Dr. Anthony Fauci is the Director of the National Institute of Allergy and Infectious Diseases, he has advised six Presidents on HIV/AIDS and many other domestic and global health issues. He was one of the principal architects of the President’s Emergency Plan for AIDS Relief (PEPFAR), a program that has saved millions of lives throughout the developing world. He is now also a member of the Coronavirus task force and talks today about the implementation of the 15 day guidelines, which we have posted and are prominently on Hannity.com.  The Sean Hannity Show is on weekdays from 3 pm to 6 pm ET on iHeartRadio and Hannity.com. Learn more about your ad-choices at https://news.iheart.com/podcast-advertisers

Lieutenant Colonel (ret.) Sam Yingst lives with his wife Katie and 4 daughters in Zambia. His job is Chief of Laboratory Infrastructure and Support, US Centers for Disease Control in Zambia. He talks about the role of the US mission in Zambia and the long-lasting impact of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) started under President George W. Bush. Sam recalls critical times in his Army career when his role in monitoring and fighting infectious were a global priority. Sam's daughters attend international schools and his wife Katie works for an NGO focused on women and infant health issues in Afghanistan. Sam reflects on the values he learned at West Point and the enduring influence they have had on his life. 

Ambassador Deborah Birx, U.S Global AIDS Coordinator and the U.S Special Representative for Global Health Diplomacy, joined the "In The Arena" podcast to discuss the development of her unique career path, her current role of overseeing the President's Emergency Plan for AIDS Relief (PEPFAR), and the future of America's global public health policy.  The post In The Arena – Episode 11: Ambassador Deborah Birx appeared first on McCain Institute.

Ambassador Deborah Birx, U.S Global AIDS Coordinator and the U.S Special Representative for Global Health Diplomacy, joined the "In The Arena" podcast to discuss the development of her unique career path, her current role of overseeing the President's Emergency Plan for AIDS Relief (PEPFAR), and the future of America's global public health policy.  The post In The Arena – Episode 11: Ambassador Deborah Birx appeared first on McCain Institute.

The President's Emergency Plan for AIDS Relief (PEPFAR) is a program that was born from bipartisan legislation in 2003 under George W. Bush's administration. It was the biggest global health investment for a single disease by any country in the world, and still is today. We sit down with Caitlin Horrigan from Planned Parenthood Federation of America to discuss the evolution of PEPFAR, the ways in which it has provided care for HIV/AIDS patients around the world, and the attacks it is now facing from the Trump administration. Support the show (https://www.reprosfightback.com/take-action#donate)

1.8 million HIV-infected people will die over the next 10 years in South Africa if US President Donald Trump cut foreign aid supporting HIV/AIDS treatment. This is according to a global study by the Annals of Internal Medicine. According to scientists and researchers globaly; sky-rocketing deaths in the African nations would far outweigh savings.The President's Emergency Plan for Aids Relief (PEPFAR) funding will now be $5 billion per year compared to the previous $6 billion, However, US State Department says no patient currently receiving antiretroviral therapy through PEPFAR funds will lose that treatment. Tsepiso Makwetla spoke to Treatment Action Campaign's General Secretary, Anele Yawa

Special World Aids Day podcast! Our latest guest, Dr. Tom Quinn, was one of the first doctors working on HIV/AIDS here in the US in 1981 and still in the frontlines of combatting this global epidemic as Director of the Johns Hopkins Center for Global Health, Associate Director for International Research at the National Institutes of Health (NIH), a researcher at Johns Hopkins University, and a consultant at a long list of places like The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), World Health Organization (WHO). Truly a champion for public health. Check out our show links at www.publichealthunited.org and follow us on Twitter, Instagram and Facebook at PHUpodcast.

Michael Gerson is a nationally syndicated columnist who appears twice weekly in the Washington Post. He is the author of Heroic Conservatism (HarperOne, 2007) and co-author of City of Man: Religion and Politics in a New Era (Moody, 2010). Gerson serves as Senior Advisor at ONE, a bipartisan organization dedicated to the fight against extreme poverty and preventable diseases. He is the Hastert Fellow at the J. Dennis Hastert Center for Economics, Government, and Public Policy at Wheaton College in Illinois. He serves on the United States Holocaust Memorial Council, the Holocaust Memorial Museum's Committee on Conscience, the Board of Directors of Bread for the World, the Initiative for Global Development Leadership Council, and the Board of Directors of the International Rescue Committee. He is co-Chair of The Poverty Forum and Co-Chair of the Catholic/Evangelical Dialogue with Dr. Ron Sider. From 2006 to 2009, Gerson was the Roger Hertog Senior Fellow at the Council on Foreign Relations (CFR). Before joining CFR in 2006, Gerson was a top aide to President George W. Bush as Assistant to the President for Policy and Strategic Planning. He was a key administration advocate for the President's Emergency Plan for AIDS Relief (PEPFAR), the President's Malaria Initiative (PMI), the fight against global sex trafficking, and funding for women's justice and empowerment issues. Prior to that appointment, he served in the White House as Deputy Assistant to the President and Director of Presidential Speechwriting and Assistant to the President for Speechwriting and Policy Advisor. Gerson joined Bush's presidential campaign in early 1999 as chief speechwriter and a senior policy adviser. He was previously a senior editor covering politics at U.S. News and World Report. Gerson was a speechwriter and policy adviser for Jack Kemp and a speechwriter for Bob Dole during the 1996 presidential campaign. He has also served Senator Dan Coats of Indiana as Policy Director. Gerson is a graduate of Wheaton College in Illinois. He grew up in the St. Louis area and now lives with his wife and sons in northern Virginia.

Speaker(s): Dr. Anthony So, Introductory remarks; Dr. Peter Mugyenyi,, Founder and Director of the Join Clinical Research Center in Kampala, Uganda, speaks on the impact of the President’s Emergency Plan for AIDS Relief (PEPFAR) in the Ugandan context and the current strategy to harness HIV/AIDS treatment as a means of prevention. Dr. Mugyenyi also addresses the great importance of U.S. foreign aid, a necessary component, he argues, for true success in the fight against AIDS.

Speaker(s): Dr. Anthony So, Introductory remarks; Dr. Peter Mugyenyi, Founder and Director of the Join Clinical Research Center in Kampala, Uganda, speaks on the impact of the President’s Emergency Plan for AIDS Relief (PEPFAR) in the Ugandan context and the current strategy to harness HIV/AIDS treatment as a means of prevention. Dr. Mugyenyi also addresses the great importance of U.S. foreign aid, a necessary component, he argues, for true success in the fight against AIDS.

According to UNAIDS, 33.4 million people are living with HIV worldwide, and approximately 2.7 million new infections occurred in 2008. For every two people who start treatment, five more are infected. Undoubtedly, this global epidemic requires a comprehensive, multisectoral approach that expands access to prevention, care, and treatment.America is leading the fight against global HIV/AIDS through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) – the largest commitment by any nation to combat a single disease internationally in history. The human impact of America’s investments in partner nations’ efforts is profound. Through PEPFAR, the United States has directly supported life-saving antiretroviral treatment for over 2.4 million people, and care for more than 11 million people with care and support programs, including more than 4 million orphans and vulnerable children. PEPFAR’s efforts around prevention of mother-to-child transmission programs have allowed nearly 340,000 babies of HIV-positive mothers to be born HIV-free. PEPFAR is the cornerstone and largest component of the President’s Global Health Initiative, which supports partner countries in improving health outcomes through strengthened health systems. Responsible for overseeing US-sponsored programs to combat the HIV/AIDS epidemic worldwide, Ambassador Eric Goosby joins the Council to discuss the Obama Administration’s commitment to the fight against global AIDS. Ambassador Goosby has over 25 years of experience with HIV/AIDS, ranging from his early years treating patients at San Francisco General Hospital when AIDS first emerged, to engagement at the highest level of policy leadership.